Celltrion Trio's Joint Rally...Driving KOSDAQ Past 1000 Mark

[Image source=Yonhap News]

[Asia Economy Reporter Park Ji-hwan] On the 26th, the stock prices of the three Celltrion companies?Celltrion, Celltrion Healthcare, and Celltrion Pharm?showed simultaneous gains. On this day, the KOSDAQ index surpassed 1000 points for the first time in history. It is interpreted that the top market capitalization stocks, Celltrion Healthcare and Celltrion Pharm, are driving the index up as investor sentiment is influenced by expectations for the approval of Celltrion's novel coronavirus disease (COVID-19) treatment.

As of 9:58 a.m. on the 26th, Celltrion was trading at 331,500 KRW, up 10,500 KRW (3.27%) from the previous day. At the same time, Celltrion Healthcare was trading at 157,700 KRW, up 3.54%, and Celltrion Pharm was trading at 193,900 KRW, up 5.26%.

The strong stock performance of these companies is interpreted as reflecting expectations that approval for the COVID-19 treatment is imminent. Earlier, the Ministry of Food and Drug Safety announced in a government report on the 25th that "both overseas COVID-19 vaccines and domestic treatments are expected to be approved next month."